Prominin-1 (CD133) is physiologically expressed at the apical membranes of secretory (serous and mucous) and duct cells of major salivary glands. We investigated its expression in various human salivary gland lesions using two distinct anti-prominin-1 monoclonal antibodies (80B258 and AC133) applied on paraffin-embedded sections and characterized its occurrence in saliva. The 80B258 epitope was extensively expressed in adenoid cystic carcinoma, in lesser extent in acinic cell carcinoma and pleomorphic adenoma, and rarely in mucoepidermoid carcinoma. The 80B258 immunoreactivity was predominately detected at the apical membrane of tumor cells showing acinar or intercalated duct cell differentiation, which lined duct- or cyst-like structures, and in luminal secretions. It was observed on the whole cell membrane in non-luminal structures present in the vicinity of thin-walled blood vessels and hemorrhagic areas in adenoid cystic carcinoma. Of note, AC133 labeled only a subset of 80B258-positive structures. In peritumoral salivary gland tissues as well as in obstructive sialadenitis, an up-regulation of prominin-1 (both 80B258 and AC133 immunoreactivities) was observed in intercalated duct cells. In most tissues, prominin-1 was partially co-expressed with two cancer markers: carcinoembryonic antigen (CEA) and mucin-1 (MUC1). Differential centrifugation of saliva followed by immunoblotting indicated that all three markers were released in association with small membrane vesicles. Immuno-isolated prominin-1-positive vesicles contained CEA and MUC1, but also exosome-related proteins CD63, flotillin-1, flotillin-2 and the adaptor protein syntenin-1. The latter protein was shown to interact with prominin-1 as demonstrated by its co-immunoisolation. A fraction of saliva-associated prominin-1 appeared to be ubiquitinated. Collectively, our findings bring new insights into the biochemistry and trafficking of prominin-1 as well as its immunohistochemical profile in certain types of salivary gland tumors and inflammatory diseases.

Department of Histology and Embryology Charles University Prague Faculty of Medicine and University Hospital Hradec Králové Prague Czech Republic

Max Planck Institute of Molecular Cell Biology and Genetics Dresden Germany

The Fingerland Department of Pathology Charles University Prague Faculty of Medicine and University Hospital Hradec Králové Prague Czech Republic

Tissue Engineering Laboratories BIOTEC Technische Universität Dresden Dresden Germany

Tissue Engineering Laboratories BIOTEC Technische Universität Dresden Dresden Germany; Department of Histology and Embryology Charles University Prague Faculty of Medicine and University Hospital Hradec Králové Prague Czech Republic

Zobrazit více v PubMed

Weigmann A, Corbeil D, Hellwig A, Huttner WB (1997) Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 94: 12425–12430. PubMed PMC

Röper K, Corbeil D, Huttner WB (2000) Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2: 582–592. PubMed

Fargeas CA, Florek M, Huttner WB, Corbeil D (2003) Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins. J Biol Chem 278: 8586–8596. PubMed

Corbeil D, Karbanová J, Fargeas CA, Jászai J (2013) Prominin-1 (CD133): Molecular and Cellular Features Across Species. Adv Exp Med Biol 777: 3–24. PubMed

Fargeas CA (2013) Prominin-2 and Other Relatives of CD133. Adv Exp Med Biol 777: 25–40. PubMed

Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002–5012. PubMed

Uchida N, Buck DW, He D, Reitsma MJ, Masek M, et al. (2000) Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97: 14720–14725. PubMed PMC

Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S, et al. (2000) The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 275: 5512–5520. PubMed

Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 117: 3539–3545. PubMed

Corbeil D, Fargeas CA, Jászai J (2014) CD133 might be a pan marker of epithelial cells with dedifferentiation capacity. Proc Natl Acad Sci U S A 111: E1451–1452. PubMed PMC

Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756–760. PubMed

Liu G, Yuan X, Zeng Z, Tunici P, Ng H, et al. (2006) Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67. PubMed PMC

Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, et al. (2009) The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 219: 427–434. PubMed

Al Dhaybi R, Sartelet H, Powell J, Kokta V (2010) Expression of CD133+ cancer stem cells in childhood malignant melanoma and its correlation with metastasis. Mod Pathol 23: 376–380. PubMed

Grosse-Gehling P, Fargeas CA, Dittfeld C, Garbe Y, Alison MR, et al. (2013) CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol 229: 355–378. PubMed

Fargeas CA, Fonseca AV, Huttner WB, Corbeil D (2006) Prominin-1 (CD133): from progenitor cells to human diseases. Future Lipidology 1: 213–225.

Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, et al. (2005) Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319: 15–26. PubMed

Lardon J, Corbeil D, Huttner WB, Ling Z, Bouwens L (2008) Stem cell marker prominin-1/AC133 is expressed in duct cells of the adult human pancreas. Pancreas 36: e1–6. PubMed

Karbanová J, Missol-Kolka E, Fonseca AV, Lorra C, Janich P, et al. (2008) The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia. J Histochem Cytochem 56: 977–993. PubMed PMC

Missol-Kolka E, Karbanová J, Janich P, Haase M, Fargeas CA, et al. (2011) Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 71: 254–267. PubMed

Marzesco AM, Janich P, Wilsch-Bräuninger M, Dubreuil V, Langenfeld K, et al. (2005) Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118: 2849–2858. PubMed

Dubreuil V, Marzesco AM, Corbeil D, Huttner WB, Wilsch-Bräuninger M (2007) Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1. J Cell Biol 176: 483–495. PubMed PMC

Ogawa Y, Miura Y, Harazono A, Kanai-Azuma M, Akimoto Y, et al. (2011) Proteomic analysis of two types of exosomes in human whole saliva. Biol Pharm Bull 34: 13–23. PubMed

Berckmans RJ, Sturk A, van Tienen LM, Schaap MC, Nieuwland R (2011) Cell-derived vesicles exposing coagulant tissue factor in saliva. Blood 117: 3172–3180. PubMed

Huttner HB, Janich P, Kohrmann M, Jászai J, Siebzehnrubl F, et al. (2008) The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease. Stem Cells 26: 698–705. PubMed

Huttner HB, Corbeil D, Thirmeyer C, Coras R, Kohrmann M, et al. (2012) Increased membrane shedding—indicated by an elevation of CD133-enriched membrane particles—into the CSF in partial epilepsy. Epilepsy Res 99: 101–106. PubMed

Marzesco AM (2013) Prominin-1-containing membrane vesicles: origins, formation, and utility. Adv Exp Med Biol 777: 41–54. PubMed

Bauer N, Wilsch-Bräuninger M, Karbanová J, Fonseca AV, Strauss D, et al. (2011) Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles—a role of the endocytic-exocytic pathway. EMBO Mol Med 3: 398–409. PubMed PMC

Jászai J, Janich P, Farkas LM, Fargeas CA, Huttner WB, et al. (2007) Differential expression of Prominin-1 (CD133) and Prominin-2 in major cephalic exocrine glands of adult mice. Histochem Cell Biol 128: 409–419. PubMed

Ellis GL, Auclair PL (2008) Tumors of salivary glands. Silver Spring MD: ARP Press. 524 p.

Caselitz J, Seifert G, Jaup T (1981) Presence of carcinoembryonic antigen (CEA) in the normal and inflamed human parotid gland. An immunohistochemical study of 31 cases. J Cancer Res Clin Oncol 100: 205–211. PubMed

Liu B, Lague JR, Nunes DP, Toselli P, Oppenheim FG, et al. (2002) Expression of membrane-associated mucins MUC1 and MUC4 in major human salivary glands. J Histochem Cytochem 50: 811–820. PubMed

Alos L, Lujan B, Castillo M, Nadal A, Carreras M, et al. (2005) Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol 29: 806–813. PubMed

Handra-Luca A, Lamas G, Bertrand JC, Fouret P (2005) MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 29: 881–889. PubMed

Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, et al. (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3: 223–232. PubMed

Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, et al. (1989) Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327–334. PubMed

Hammarstrom S (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin Cancer Biol 9: 67–81. PubMed

Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, et al. (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18: 1295–1304. PubMed

Mall AS (2008) Analysis of mucins: role in laboratory diagnosis. J Clin Pathol 61: 1018–1024. PubMed

Goldstein MJ, Mitchell EP (2005) Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest 23: 338–351. PubMed

Hayes DF, Sekine H, Ohno T, Abe M, Keefe K, et al. (1985) Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 75: 1671–1678. PubMed PMC

Sekine H, Hayes DF, Ohno T, Keefe KA, Schaetzl E, et al. (1985) Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. J Clin Oncol 3: 1355–1363. PubMed

Angelov A, Klissarova A, Dikranian K (1996) Radioimmunological and immunohistochemical study of carcinoembryonic antigen in pleomorphic adenoma and mucoepidermoid carcinoma of the salivary glands. Gen Diagn Pathol 141: 229–234. PubMed

He H, Chen GF, Zhou L, Liu YM (2009) A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland. J Cancer Res and Clin Oncol 135: 1315–1321. PubMed

Streckfus C, Bigler L, Tucci M, Thigpen JT (2000) A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest 18: 101–109. PubMed

Brooks MN, Wang J, Li Y, Zhang R, Elashoff D, et al. (2008) Salivary protein factors are elevated in breast cancer patients. Mol Med Report 1: 375–378. PubMed PMC

Agha-Hosseini F, Mirzaii-Dizgah I, Rahimi A (2009) Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal 14: e521–524. PubMed

Boshell M, Lalani EN, Pemberton L, Burchell J, Gendler S, et al. (1992) The product of the human MUC1 gene when secreted by mouse cells transfected with the full-length cDNA lacks the cytoplasmic tail. Biochem Biophys Res Commun 185: 1–8. PubMed

Zhang K, Baeckstrom D, Brevinge H, Hansson GC (1996) Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 60: 538–549. PubMed

Julian J, Carson DD (2002) Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun 293: 1183–1190. PubMed

Dai S, Wan T, Wang B, Zhou X, Xiu F, et al. (2005) More efficient induction of HLA-A*0201-restricted and carcinoembryonic antigen (CEA)-specific CTL response by immunization with exosomes prepared from heat-stressed CEA-positive tumor cells. Clin Cancer Res 11: 7554–7563. PubMed

Kesimer M, Scull M, Brighton B, DeMaria G, Burns K, et al. (2009) Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense. Faseb J 23: 1858–1868. PubMed PMC

Das SK, Bhutia SK, Kegelman TP, Peachy L, Oyesanya RA, et al. (2012) MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front Biosci 17: 1–15. PubMed

Barnes L, Evenson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumors. Pathology and genetics of the head and neck tumors. Lyon: IARC Press. 430 p.

Verstijnen CP, Arends JW, Moerkerk PT, Warnaar S, Hilgers J, et al. (1986) CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies. Anticancer Res 6: 97–104. PubMed

Caselitz J, Jaup T, Seifert G (1981) Immunohistochemical detection of carcinoembryonic antigen (CEA) in parotid gland carcinomas. Analysis of 52 cases. Virchows Arch A Pathol Anat Histol 394: 49–60. PubMed

Hilkens J, Buijs F, Hilgers J, Hageman P, Calafat J, et al. (1984) Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 34: 197–206. PubMed

Corbeil D, Fargeas CA, Huttner WB (2001) Rat prominin, like its mouse and human orthologues, is a pentaspan membrane glycoprotein. Biochem Biophys Res Commun 285: 939–944. PubMed

Price MR, Rye PD, Petrakou E, Murray A, Brady K, et al. (1998) Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996. Tumour Biol 19 Suppl 1: 1–20. PubMed

Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, et al. (1997) Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays. Clin Chem 43: 585–593. PubMed

Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, et al. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166: 7309–7318. PubMed

Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A (2008) Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 8: 48. PubMed PMC

Bidlingmaier S, Zhu X, Liu B (2008) The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med (Berl) 86: 1025–1032. PubMed PMC

Fargeas CA, Karbanová J, Jászai J, Corbeil D (2011) CD133 and membrane microdomains: old facets for future hypotheses. World J Gastroenterol 17: 4149–4152. PubMed PMC

Pringle S, Van Os R, Coppes RP (2013) Concise review: Adult salivary gland stem cells and a potential therapy for xerostomia. Stem Cells 31: 613–619. PubMed

Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, et al. (2008) Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study. Cancer Sci 99: 1578–1583. PubMed PMC

Fan L, He F, Liu H, Zhu J, Liu Y, et al. (2011) CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma. BMC Cancer 11: 320. PubMed PMC

Lester RD, Jo M, Montel V, Takimoto S, Gonias SL (2007) uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178: 425–436. PubMed PMC

Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442–454. PubMed

Imai T, Horiuchi A, Wang C, Oka K, Ohira S, et al. (2003) Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163: 1437–1447. PubMed PMC

Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE (2003) Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther 2: 255–256. PubMed

Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, et al. (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57: 965–969. PubMed PMC

Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, et al. (2011) Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 9: 997–1007. PubMed PMC

Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111–2120. PubMed PMC

Lonnroth C, Andersson M, Nordgren S, Lundholm K (2012) Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment. Int J Oncol 41: 15–23. PubMed

Chen KH, Hsu CC, Song WS, Huang CS, Tsai CC, et al. (2010) Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells. Childs Nerv Syst 26: 1605–1612. PubMed

Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, et al. (2011) Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation. J Neurosurg 114: 651–662. PubMed

Mahomed F (2011) Recent advances in mucin immunohistochemistry in salivary gland tumors and head and neck squamous cell carcinoma. Oral Oncol 47: 797–803. PubMed

Hamada T, Matsukita S, Goto M, Kitajima S, Batra SK, et al. (2004) Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence. J Clin Pathol 57: 813–821. PubMed PMC

Soares AB, Demasi AP, Altemani A, de Araujo VC (2011) Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma. Histopathology 58: 377–382. PubMed

Rappa G, Mercapide J, Anzanello F, Pope RM, Lorico A (2013) Biochemical and biological characterization of exosomes containing prominin-1/CD133. Mol Cancer 12: 62. PubMed PMC

Marzesco AM, Wilsch-Bräuninger M, Dubreuil V, Janich P, Langenfeld K, et al. (2009) Release of extracellular membrane vesicles from microvilli of epithelial cells is enhanced by depleting membrane cholesterol. FEBS Lett 583: 897–902. PubMed

Baranov V, Yeung MM, Hammarstrom S (1994) Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies. Cancer Res 54: 3305–3314. PubMed

Staubach S, Razawi H, Hanisch FG (2009) Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9: 2820–2835. PubMed

Beekman JM, Coffer PJ (2008) The ins and outs of syntenin, a multifunctional intracellular adaptor protein. J Cell Sci 121: 1349–1355. PubMed

Latysheva N, Muratov G, Rajesh S, Padgett M, Hotchin NA, et al. (2006) Syntenin-1 is a new component of tetraspanin-enriched microdomains: mechanisms and consequences of the interaction of syntenin-1 with CD63. Mol Cell Biol 26: 7707–7718. PubMed PMC

Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, et al. (2012) Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 14: 677–685. PubMed

Pisitkun T, Shen RF, Knepper MA (2004) Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci U S A 101: 13368–13373. PubMed PMC

Fargeas CA, Huttner WB, Corbeil D (2007) Nomenclature of prominin-1 (CD133) splice variants - an update. Tissue Antigens 69: 602–606. PubMed

Rajesh S, Bago R, Odintsova E, Muratov G, Baldwin G, et al. (2011) Binding to syntenin-1 protein defines a new mode of ubiquitin-based interactions regulated by phosphorylation. J Biol Chem 286: 39606–39614. PubMed PMC

Okumura F, Yoshida K, Liang F, Hatakeyama S (2011) MDA-9/syntenin interacts with ubiquitin via a novel ubiquitin-binding motif. Mol Cell Biochem 352: 163–172. PubMed

Mak AB, Nixon AM, Kittanakom S, Stewart JM, Chen GI, et al. (2012) Regulation of CD133 by HDAC6 promotes beta-catenin signaling to suppress cancer cell differentiation. Cell Rep 2: 951–963. PubMed PMC

Tauro BJ, Greening DW, Mathias RA, Mathivanan S, Ji H, et al. (2013) Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics 12: 587–598. PubMed PMC

Kosodo Y, Röper K, Haubensak W, Marzesco AM, Corbeil D, et al. (2004) Asymmetric distribution of the apical plasma membrane during neurogenic divisions of mammalian neuroepithelial cells. EMBO J 23: 2314–2324. PubMed PMC

Emerging roles of prominin-1 (CD133) in the dynamics of plasma membrane architecture and cell signaling pathways in health and disease